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Abstract 
Background: We have investigated cancer patient satisfaction with care and the 
extent to which it varies between and within hospitals. 
Design and methods. A national survey of cancer patients in England with questions 
in ten different dimensions for four common cancers: breast, colorectal, lung and 
prostate (55,674 patients). We compared hospitals across tumour types, and against 
the national average. 
Results:  Dissatisfaction was greater (p<0.001) in younger, female patients. Breast 
cancer patients expressed least, and prostate cancer greatest dissatisfaction. Breast, 
colorectal and prostate cancers showed significant (p<0.001) pair-wise correlations 
for standardised satisfaction scores, particularly for in-hospital care.  Summed 
hospital satisfaction scores showed significant associations across different 
dimensions of care.  
Conclusions: Cancer patient satisfaction is measurably different between hospitals, as 
well as by tumour type. For many aspects of care there is evidence of systemic 
hospital-level factors that influence satisfaction as well as factors common to the care 
pathways experienced by individual patients. Factors amenable to clinical or 
managerial intervention deserve further investigation.   
Keywords 
Patient satisfaction; surveys; quality of care; cancer; breast, colo-rectum; lung.
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Introduction 
Quality in health care can be assessed through quantitative measures [1], and patient 
satisfaction is an important dimension, complementing measures of institutional 
performance and clinical outcome.  Satisfaction is itself multi-dimensional, reflecting 
the range of experiences that an individual may have during illness. A systematic 
review of 139 articles reported that correlates of patient satisfaction include personal 
health status, age and ethnicity, as well as with the provision of information and 
choice of service [2]. 
 
Cancer is the second commonest cause of death in developed countries and a frequent 
reason for hospital care.  However, cancer symptoms, treatment and survival are 
strongly determined by the pathological origin of the cancer, and clinical studies of 
cancer patients are usually made within cancer types.  Measures of satisfaction with 
care for cancer patients have been developed for clinical studies [3], and used in 
hospitals [4], but less for comparison of cancer services. Sandoval and colleagues [5, 
6], using data collected from cancer services in Ottawa, Canada, have identified 
hospital staff and informational dimensions associated with patient‟s perceptions of 
quality of care. In cancer palliative care, Fakhoury, Addington-Hall & McCarthy [7] 
found that informal care-givers‟ satisfaction was related to frequency of visits of 
healthcare staff. 
 
Variations in clinical outcomes can be affected by health service organisational 
characteristics.  Hospital factors that may affect survival in cancer care include 
volume (overview [8], and for breast and prostate cancer surgery [9, 10]); 
specialisation, (eg colorectal and ovarian cancers[11,12]); treatment standards (eg 
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colorectaland breast cancers [13, 14]; staffing levels [15] and academic (teaching or 
specialist) hospital status [16, 17]. But there is less evidence for organisational factors 
relating to satisfaction.  
 
The UK National Health Service (NHS) has embraced patient surveys for the 
assessment of hospital-level services.  Survey results have been used in performance 
indicators published by the national regulatory body [18]. The Picker satisfaction 
questionnaire has been validated in comparison with three others [4], and used in both 
general hospital surveys and surveys for specific diseases including heart disease, 
accidents, mental health and cancer [19]. The national cancer survey was made to 
support the Cancer Plan for England [20], and included patients with six common 
cancers [21].    
 
We have made secondary analyses of the NHS cancer patient satisfaction survey to 
investigate whether responses to questions varied by tumour types, and the extent to 
which the responses for different aspects of the care process were related by hospital. 
In this way we could identify the extent to which satisfaction is affected by the care 
teams that work with individual patients as well as the overall cancer care offered by 
the hospital.  Ethics approval was given by the South East Regional Ethics Committee 
(UK). 
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Methods 
 
The survey of NHS cancer patients was undertaken by an independent organisation, 
the National Centre for Surveys and Research (NCSR), using a random sample from a 
national (England) sampling frame. Patients were identified from hospital 
admission/discharge registers, and a postal questionnaire sent to the patient‟s address. 
The survey was carried out in 2000/01 and received responses from 65,337 patients 
diagnosed with one of six types of cancer in relation to one episode of in-hospital care 
in 1999(22). The response rate overall was 74%, ranging from 77% for breast cancer 
to 62% for lung cancer, and between hospitals from under 60% to over 80%(21). We 
investigated the four commonest cancers: breast (25,772) colorectal (15,891), lung 
(4011) and prostate (10,992), a total of 55,674 respondents. 
 
Questions were developed by the NCSR, and patient responses were dichotomised 
according to whether they reflected a perceived problem with that aspect of care. 
Drawing from 60 questions, the NCSR undertook a factor analysis to construct ten 
dimensions with adequate inter-item correlations, and a single lead question within 
each dimension [22]. We used these single item questions to assess inter-relationships 
of the ten dimensions between hospitals and tumour types. 
  
The ten dimensions are shown in Table 1. Single lead questions were used for nine of 
them, while a tenth dimension (outpatient clinics: medical care) was constructed  
when no single lead question could be identified by the NCSR analysis [22].  For this 
dimension five questions (which related to the waiting time to see the doctor, the 
actual time spent by doctors with the patient, the perceived time spent by the doctors 
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with the patient, confidence and trust in the outpatient doctor and whether the patient 
was treated with respect and dignity as an outpatient) were amalgamated into one 
single question, and defined as a patient having a problem with any of the five 
aspects.  Using the dichotomy of question responses, “problem” or “no problem” used 
by NCSR, we made a logistic regression analysis of the relationship between 
response and age, gender and tumour type, whilst correcting for variations between 
hospitals.  
 
To address the likelihood of response set bias, we also analysed the data using 
internal standardisation. The first step was to calculate the expected proportions of 
patients expressing a problem with each aspect of care given the tumour type and age-
sex composition of the hospital. After stratifying with respect to age and sex, these 
expected outcomes were estimated from the observed national rates. To compare 
actual performance against the expected we calculated a z-score by subtracting the 
expected number of recorded problems from the observed number and dividing by the 
standard deviation [23]. The standard deviation was obtained by assuming that the 
observed values within each stratum were binomially distributed about the national 
mean. To compensate for over-dispersion each z-score was then adjusted by inflating 
the variance appropriately [24]. These adjusted z-scores reflect the performance of 
each hospital with respect to each questionnaire dimension and, being standardised, 
with a mean of zero and variance equal to one, are mutually comparable and reduce 
any response bias. Further details are given in the Appendix. To measure whether 
satisfaction varied across tumour types within hospitals we correlated z-scores for 
each tumour type pair-wise by calculating Pearson correlation coefficients. 
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We also analysed the combination of z-scores for each particular hospital in order to 
judge the extent with which outcomes for individual hospitals are similar across all 
ten care dimensions. Our null hypothesis was that, at the hospital level, there was no 
similarity with regard to quality across the different aspects of care, so that any 
correlations between the different dimensions occur at the individual patient level. 
For each tumour type we summed each hospital‟s set of z-scores and divided the total 
by the standard deviation, calculated assuming the null hypothesis, i.e. we adjusted 
for correlations at the individual patient level . This gave us an overall score for each 
hospital that reflected levels of patient satisfaction across the ten care dimensions. 
Under the null hypothesis, the variances of these scores would be equal to one. Again, 
further details are described in the appendix. After testing for normality using a 
Kolmogorov-Smirnov one sample Test [25], we compared the observed variance with 
the null hypothesis of unit variance using a chi-squared test. 
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Results 
The overall number of respondents to each question and the proportion indicating a 
problem with the corresponding aspect of care are shown by tumour type in Table 2. 
The highest proportion of patients reported problems in relation to experience of pain 
and discomfort (dimension 5) whilst only a small proportion of patients indicated 
problems with privacy at outpatients clinics (dimension 10). 
 
Within some dimensions there appear to be large differences between tumour types, 
in particular with access to care (dimension 1); for other dimensions the results across 
tumour types are more uniform, e.g. respect and communication at first treatment 
(dimension 4) and aftercare (dimension 8).  The proportion of patients reporting 
problems was generally lower for breast cancer compared with the other three tumour 
types, except for outpatient aftercare (dimension 9).  
 
The results of analysing the relationship between response and age, gender and 
tumour type by logistic regression are shown in Table 3.  Correcting for the other 
factors, patients indicating problems tend to be younger or female. However, breast 
and lung cancer patients are inclined to indicate fewer problems than patients with 
colorectal cancer, while prostate cancer patients tend to specify more problems. 
 
Pair-wise correlations of hospital-wide adjusted satisfaction scores between each 
tumour type by care dimension are shown in Table 4. Satisfaction scores were 
correlated (p<0.001) for colorectal and breast cancer in eight out of ten dimensions of 
care, between colorectal and prostate, and breast and prostate, in five dimensions, and 
for lung with the other cancers in three and two dimensions.  Table 4 also shows more 
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correlation of satisfaction scores for dimensions relating to the hospital period of the 
episode (dimensions 4 - 6), and more variation between tumour types for pre- and 
post-hospital care (dimensions 1 - 3, and 7 - 10).  
 
To assess the presence of an independent hospital effect, the individual z-scores for 
each hospital were summed over all ten aspects of care and divided by the standard 
deviation to generate an overall satisfaction score. The distribution of the resulting 
satisfaction scores for colorectal cancer is shown in Figure 1 together with the fitted 
normal distribution and the standard normal curve for comparison. Testing these 
scores (Table 5) indicated that, for each tumour type, it was reasonable to assume a 
normal distribution. We could therefore compare the observed variances of the scores 
with a null hypothesis of unit variance using chi-squared tests, and these showed 
significant differences for each tumour type (Table 5). This indicates that the cancer 
patient satisfaction scores were correlated not only for individuals, but also 
independently at hospital level. 
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Discussion 
We investigated whether hospitals may have an independent effect on cancer patient 
satisfaction with their care.  We were able to compare patient answers across 
hospitals, tumour types and dimensions of care by using z-score standardisation for 
each dimension of care. To an extent this also reduces response bias by normalising 
the responses to each question. We found that hospital satisfaction varies by cancer 
type (for breast, colorectal, lung and prostate cancer patients), and with more effect on 
in-hospital than out-of-hospital care.  We also found that the cancer patient 
satisfaction scores were correlated not only for individuals, but also independently at 
hospital level. 
 
Limitations of the study 
There were moderate associations of satisfaction by patients treated at the same 
hospital for three different cancer diagnoses, but less similarity in responses across 
the different cancers for the pre- and post-hospital dimensions, which may reflect real 
differences in patterns of care specific to the cancer types.  Our findings took account 
of greater dissatisfaction reported among younger and female patients, and for 
colorectal and prostate cancers.  Differences in patient socio-economic 
characteristics, and in stage and co-morbidity case-mix, are important for cancer 
survival [26]. We had no data available to adjust for these, and they could be 
confounding factors.  
 
A larger body of work (indicated earlier) has related hospital characteristics to cancer 
patient survival.  The satisfaction survey did not give details of hospital 
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characteristics.  Apart from volume, physician specialisation, standards, staffing and 
academic (teaching) status, other potential hospital-related factors affecting cancer 
patient satisfaction might include hospital specialisation [27] and variation in 
geographical access [28].  Moreover, information and communication [29] 
 
are of 
particular concern to cancer patients, and these might also be structured 
systematically by hospital as well as individual clinician. 
 
Satisfaction of lung cancer patients was less strongly correlated than for other 
cancers.  This finding may be partly an artefact, relating to the considerably shorter 
survival of lung cancer compared with breast, colorectal and prostate cancers, and 
therefore greater selection of patients: there could have been a greater proportion of 
sicker patients, with less satisfaction in outcome, in the survivors interviewed.  
Differences in treatment experienced (eg proportion given surgery, radiotherapy or 
chemotherapy) could also affect satisfaction responses.  
 
Strengths of the study 
A strength of this study is that we have been able to overcome some of the potential 
problems in analysing survey data. In particular, we have attempted to quantify the 
extent to which consistent responses across different aspects of care are due to 
hospital-level factors beyond the response-set of an individual patient. To reduce the 
effects of bias when assessing consistency, we have standardised outcomes in relation 
to each care dimension. We have also been able to allow for the movement of patients 
between hospitals. However, the fact that such movements occur would affect the 
independence of the overall satisfaction scores, but this only appears to affect a few, 
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perhaps specialised, hospitals, to which many patients from nearby hospitals are 
referred for treatment. 
 
Implications 
The national survey of cancer patients‟ satisfaction was a unique national survey of 
cancer care in England.  The high response rate to the survey, with 74% overall with 
65,337 replies, reflects accuracy of recent discharge addresses, and the interest of 
most patients in providing feed-back about their care.  Presentation of hospital 
differences in cancer care in a public sphere, as for example in Ontario [30] and UK 
[31], may encourage managers and patients to become more aware of quality 
measures. From our analysis, improvements of care within hospitals are more likely 
to impact on all cancer types, while care before and after hospitalisation would need 
action that is more cancer-type specific.  Further investigation of explanatory 
characteristics of variations in cancer patients‟ satisfaction with care is warranted.   
 
 
Appendix 
For a particular tumour type, let πqi denote the national proportion of patients in age-
sex stratum i who specify a problem with question q. Also, within hospital t, let ntqi 
denote the number of respondents to question q in stratum i and mtqi the number who 
specify a problem. Then the z-score for hospital t in relation to question q is given by: 
i
qiqitqi
i
qitqitqi
tq
n
nm
z
)1(
)(
 
If the outcomes are binomially distributed about the national mean, then these z-
scores will have expected value equal to zero and a variance of one. 
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To adjust for over-dispersion in these z-scores we calculate the quantity: 
T
z
s
t
tq
q
2
 
then use this in adjusting the z-scores:  
q
tq
tq
s
z
z
*
 
 
We now put 
q
tqt
zY
* , the sum of each hospital‟s z-scores over the ten questions. 
The expected value of Yt will be zero, and the variance can be approximated by: 
q qr
trtqt
zzCovYVar ),(10)(
**  
i.e. the sum of the variances of the individual z-scores and the covariances between 
each pair of questions. (Note that if a hospital has only scores for, say, nine questions 
then the first term of the above variance will be equal to nine instead of ten.) 
 
Under the null hypothesis of that, at the hospital level, there was no similarity with 
regard to quality across the different aspects of care, any correlations between the 
different dimensions are at the individual patient level. These covariances can then be 
calculated from the individual responses: if xtqik denotes the response to question q for 
patient k in stratum i and hospital t, then 
rq
i k
triktqik
rq
trtq
trtq
ss
xxCov
ss
zzCov
zzCov
),(
),(
),(
**  
If a patient refers to different hospitals in his or her responses to questions q and r, 
then the covariance in the summation will be zero. 
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The satisfaction score for each hospital is calculated as: 
)(
t
t
t
YVar
Y
Z  
Under the null hypothesis this will have a variance equal to one. 
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Table 1: The ten care dimensions within the survey. 
 
Dimension Heading Single questions used to represent each dimension 
1 Access to care: waiting times Time waiting for first appointment with doctor 
2 Explanation at first visit Time spent on explaining condition at first visit 
3 Understanding of diagnosis and treatment Whether doctor discussed the purpose of treatment with patient 
4 First treatment: respect communication and involvement Whether treated with respect and dignity by doctor/nurse 
5 First treatment: pain and discomfort Whether in pain or discomfort during first visit 
6 First treatment: hospital management Whether there were sufficient nurses on duty 
7 Discharge co-ordination Whether patient given printed information on care after discharge 
8 Aftercare Whether doctors spent enough time informing patient on aftercare 
9 Recent outpatient visit: medical care Five questions amalgamated into single composite 
10 Recent outpatient visit: privacy Privacy when discussing condition/treatment 
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Table 2: The number of respondents to each question and the proportion indicating a problem with each aspect of care. 
Dimension of 
care 
Colorectal Breast Lung Prostate 
Respondents 
% 
problems 
Respondents % problems Respondents % problems Respondents % problems 
1 (access) 12,061 37.2% 16,025 13.5% 2,865 25.4% 7,216 45.8% 
2 (explanation) 13,549 22.4% 22,525 16.6% 3,508 18.3% 8,519 28.6% 
3 (understanding) 14,421 18.0% 22,808 14.8% 3,572 19.9% 8,969 22.7% 
4 (respect) 14,508 21.8% 22,920 21.4% 3,629 19.3% 9,106 19.1% 
5 (pain) 14,417 70.8% 22,828 64.0% 3,593 58.6% 9,016 60.0% 
6 (nurses) 15,676 26.3% 25,308 26.7% 3,937 19.9% 10,753 19.2% 
7 (coordination) 14,249 32.5% 22,650 17.7% 3,535 30.2% 8,875 31.8% 
8 (aftercare) 14,210 19.1% 22,579 18.1% 3,527 21.0% 8,847 21.2% 
9 (medical) 12,621 49.6% 21,869 63.0% 3,251 48.3% 8,226 51.9% 
10 (privacy) 13,028 0.7% 22,454 0.7% 3,309 0.5% 8,424 0.6% 
Total respondents 15,891  25,772  4,011  10,992  
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Table 3: The influence of different cofactors on the chances of a patient expressing a problem with each aspect of care. Outcomes of a 
multivariate logistic regression analysis. 
Dimension of 
care 
Every five years 
of age 
Female sex 
Tumour type compared to colorectal 
Breast Prostate Lung 
Odds 
ratio 
p-value 
Odds 
ratio 
p-value 
Odds 
ratio 
p-value 
Odds 
ratio 
p-value 
Odds 
ratio 
p-value 
1 (access) 0.90 <0.001 1.16 <0.001 0.19 <0.001 1.67 <0.001 0.54 <0.001 
2 (explanation) 0.98 <0.001 0.89 0.002 0.72 <0.001 1.37 <0.001 0.79 <0.001 
3 (understanding) 1.00 0.68 1.16 <0.001 0.74 <0.001 1.43 <0.001 1.16 0.002 
4 (respect) 0.90 <0.001 1.31 <0.001 0.71 <0.001 1.06 0.11 0.89 0.02 
5 (pain) 0.92 <0.001 1.07 0.03 0.60 <0.001 0.70 <0.001 0.57 <0.001 
6 (nurses) 0.90 <0.001 1.28 <0.001 0.77 <0.001 0.83 <0.001 0.73 <0.001 
7 (coordination) 1.05 <0.001 1.51 <0.001 0.38 <0.001 1.11 0.002 1.02 0.69 
8 (aftercare) 1.01 0.37 1.55 <0.001 0.76 <0.001 1.41 <0.001 1.19 <0.001 
9 (medical) 0.91 <0.001 1.04 0.22 1.45 <0.001 1.22 <0.001 0.91 0.02 
10 (privacy) 0.83 <0.001 0.93 0.70 0.81 0.26 1.08 0.69 0.70 0.18 
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Table 4: Pairwise correlations of hospital satisfaction scores (adjusted) for each aspect of care between different tumour types. Pearson 
correlation coefficients (two-tailed p-values in parentheses). Correlations significant at the 1% level are indicated in bold. 
 
Dimension of 
care 
Colorectal v. 
breast 
Colorectal v. lung 
Colorectal v. 
prostate 
Breast v. lung Breast v. prostate Lung v. prostate 
1 (access) 0.23 (0.002) -0.30 (0.70) 0.25 (0.001) -0.02 (0.77) 0.01 (0.94) -0.04 (0.59) 
2 (explanation) 0.08 (0.30) 0.06 (0.47) 0.12 (0.14) -0.03 (0.69) 0.06 (0.41) -0.04 (0.63) 
3 (understanding) 0.23 (0.002) 0.04 (0.63) 0.04 (0.60) -0.14 (0.07) 0.06 (0.41) -0.12 (0.12) 
4 (respect) 0.35 (<0.001) 0.11 (0.15) 0.19 (0.01) -0.01 (0.88) 0.33 (<0.001) -0.02 (0.75) 
5 (pain) 0.48 (<0.001) 0.31 (<0.001) 0.40 (<0.001) 0.30 (<0.001) 0.34 (<0.001) 0.22 (0.003) 
6 (nurses) 0.55 (<0.001) 0.14 (0.08) 0.40 (<0.001) 0.22 (0.004) 0.45 (<0.001) 0.14 (0.08) 
7 (coordination) 0.38 (<0.001) 0.40 (<0.001) 0.35 (<0.001) 0.23 (0.003) 0.31 (<0.001) 0.25 (0.001) 
8 (aftercare) 0.26 (0.001) 0.19 (0.01) 0.16 (0.04) 0.10 (0.21) 0.16 (0.04) -0.04 (0.59) 
9 (medical) 0.31 (<0.001) 0.15 (0.05) 0.15 (0.04) 0.19 (0.02) 0.19 (0.01) 0.08 (0.31) 
10 (privacy) -0.06 (0.47) 0.03 (0.69) 0.12 (0.11) -0.15 (0.045) 0.09 (0.23) -0.03 (0.71) 
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Table 5: Analysis of combined satisfaction scores – tests for normality and comparison of observed variances with unit variance. 
 
Tumour type 
Test for normality 
(Kolmogorov-Smirnov 
D statistic 
p-value for D 
statistic 
Observed 
variance 
95% confidence interval 
for variance 
p-value 
Colorectal 0.57 0.91 2.06 (1.68, 2.57) < 0.001 
Breast 0.44 0.99 2.00 (1.64, 2.51) < 0.001 
Lung 0.79 0.56 1.27 (1.04, 1.59) 0.01 
Prostate 0.72 0.67 1.61 (1.31, 2.01) < 0.001 
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Figure 1.  Comparison of totalled hospital satisfaction z-scores divided by standard deviation, for colorectal cancer, compared with normal 
distribution, and fitted comparison curve 
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